Tower Research Capital (TRC)’s Orchestra BioMed OBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.8K | Buy |
27,922
+25,666
| +1,138% | +$68.8K | ﹤0.01% | 2622 |
|
|
2025
Q1 | $9.66K | Sell |
2,256
-67
| -3% | -$287 | ﹤0.01% | 3747 |
|
|
2024
Q4 | $9.29K | Buy |
2,323
+407
| +21% | +$1.63K | ﹤0.01% | 3917 |
|
|
2024
Q3 | $9.85K | Sell |
1,916
-2,969
| -61% | -$15.3K | ﹤0.01% | 3828 |
|
|
2024
Q2 | $39.8K | Buy |
4,885
+3,174
| +186% | +$25.9K | ﹤0.01% | 3270 |
|
|
2024
Q1 | $9.02K | Sell |
1,711
-757
| -31% | -$3.99K | ﹤0.01% | 3915 |
|
|
2023
Q4 | $22.5K | Buy |
2,468
+911
| +59% | +$8.32K | ﹤0.01% | 3576 |
|
|
2023
Q3 | $13.6K | Buy |
1,557
+1,012
| +186% | +$8.83K | ﹤0.01% | 3772 |
|
|
2023
Q2 | $3.82K | Sell |
545
-363
| -40% | -$2.54K | ﹤0.01% | 4996 |
|
|
2023
Q1 | $18K | Sell |
908
-1,215
| -57% | -$24.1K | ﹤0.01% | 3568 |
|
|
2022
Q4 | $21K | Hold |
2,123
| – | – | ﹤0.01% | 3096 |
|
|
2022
Q3 | $21K | Buy |
2,123
+984
| +86% | +$9.73K | ﹤0.01% | 3898 |
|
|
2022
Q2 | $11K | Buy |
1,139
+54
| +5% | +$522 | ﹤0.01% | 4383 |
|
|
2022
Q1 | $11K | Buy |
1,085
+888
| +451% | +$9K | ﹤0.01% | 4194 |
|
|
2021
Q4 | $2K | Buy |
197
+50
| +34% | +$508 | ﹤0.01% | 5644 |
|
|
2021
Q3 | $1K | Sell |
147
-545
| -79% | -$3.71K | ﹤0.01% | 5510 |
|
|
2021
Q2 | $7K | Buy |
692
+147
| +27% | +$1.49K | ﹤0.01% | 4562 |
|
|
2021
Q1 | $6K | Buy |
+545
| New | +$6K | ﹤0.01% | 4600 |
|